Blue Water Acquisition II in a letter today to the SEC said it is withdrawing a planned offering of 7.5 million units initially registered last October. A unit was to consist of one share and one-half of a warrant.
The SPAC had planned to focus on healthcare or healthcare related industries in the United States and Europe, the life sciences and pharmaceutical services sectors in particular. Chairman and CEO Joseph Hernandez, who began his career at Merck, founded or led eight entrepreneurial companies in healthcare and pharmaceuticals.
The SPAC had expected to list on the Nasdaq with Maxim serving as sole book-running manager. Read more.
